Axsome Therapeutics, Inc. (AXSM) Other
Market cap
$12.1B
P/E ratio
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | -20.1 | -37.7 | -21 | -14.3 | -24.8 | -29.2 | -21.4 | -12.9 | -4.5 |
| Return on equity (%) |
| 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | -20.1 | -37.7 | -21 | -14.3 | -24.8 | -29.2 | -21.4 | -12.9 | -4.5 |
| Return on equity (%) |